Leadership

Philippe Brudi, MD

Dr. Philippe Brudi has over 20 years of experience in the pharmaceutical industry, having held positions of increasing responsibility in clinical development and medical affairs.

Dr. Brudi was previously Executive Director of Global Medical Affairs of Diabetes & Cardiovascular Disease at Merck, where he led a global and regional medical affairs director team that wrote, implemented, and tracked the execution of global plans (including the US) developed for diabetes, atherosclerosis, thrombosis, pulmonary hypertension, and heart failure portfolios.

Other former positions Dr. Brudi has held are: Global Clinical Research & Medical Affairs Head at Novartis (Switzerland), Cardiovascular Medical Director at Bristol-Myers Squibb (France and US), and Cardiovascular Medical Advisor at Zeneca Pharma (France). With his strong communicational skills, high energy levels, and ability to solve complex problems in a fast-paced environment, Dr. Brudi holds a track record in launching new treatments for diabetes and cardiovascular disease. He is internationally connected with a diverse network of experts in metabolic diseases and cardiology.

Dr. Brudi holds an MBA from IMIS (Lyon, France) and a MD specialized in primary care from University of Nancy II (France). He is a member of the American National Lipid Association (NLA), the American Heart Association (AHA), the European Society of Cardiology (ESC), and the European Society of Atherosclerosis (EAS). He has published over 60 peer-reviewed articles and over 120 cardiovascular metabolic posters and communications.

 

Leadership List

Officers

G. Alexander Fleming, MD
Founder and Executive Chairman

Thomas Seoh, J.D.
President and Chief Executive Officer

Brian Oscherwitz, MBA, PMP
Chief Operating Officer

 

Clinical Development

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Brian E. Harvey, MD, Ph.D

Charles Alexander, MD

Doug Muchmore, MD

Giora Davidai, MD

Gordon B. Cutler, Jr., M.D.

Grant Williams, MD

Guenther Karmann, Ph.D

John K. Whisnant, Jr, MD

Michael Trautmann, MD

Mustafa A. Noor, MD, FACP

Peter Damsbo, MD

Ramachandra (Ram) G. Naik, M.D.

Simon Bruce, MD

Theo Gana, MD, Ph.D

Todd J. Lorenz, MD

 

Regulatory Strategy and Operations

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Asoke Mukherjee, Ph.D

Brian E. Harvey, MD, Ph.D

Catherine Bernard, Ph.D

David Reinhold Brill, Ph.D

Dia Hill

Frances Mielach, Ph.D, RP.h

Gabrielle Wiederkehr, MSc

Grant Williams, MD

Joshua Sharlin, Ph.D

Michael Sharp, Ph.D

Susan Manley, MS

 

Biostatistics

Alan Fisher, DrPH

 

EU Regulatory

Catherine Bernard, Ph.D

Gabrielle Wiederkehr, MSc

Michael Trautmann, MD

 

Clinical Operations/Project Management

Brian Oscherwitz, MBA, PMP

Chris Yun, B.S.

Gabrielle Wiederkehr, MSc

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Susan Manley, MS

 

Pre-Clinical

Asoke Mukherjee, Ph.D

Dave Edwards, Ph.D

Frances Mielach, Ph.D, RP.h

Joy Cavagnaro, Ph.D

Michael B. Zemel, Ph.D.

Virgil Whitehurst, Ph.D

 

CMC, Formulation/Process Development & Sourcing

Anand Khedkar, Ph.D

David Bergstrom, Ph.D

Jo Van Betsbrugge, PhD

Knut Zellerhoff, Ph.D

Robert Kaster, RPh., ASQ-CQA

 

Medical Device

Michael Sharp, Ph.D

 

QA/QC

Brian Oscherwitz, MBA, PMP

Jennifer Zhao, B.S.

 

Medical Writing/Electronic Submissions

Jennifer Zhao, B.S.

Kristi Hultberg, B.S.

Sandor Bernath, Ph.D, MBA

 

Botanicals

Jinhui Dou, Ph.D.

 

Government Relations and Public Affairs

Scot Faulkner, MPA

 

Defense & National Security Practice

Dean E.Calcagni, MD

 

Commercialization and Business & Corporate Strategy

Brian Oscherwitz, MBA, PMP

Lisa Jansa, MBA

Martin Lafontaine

Thomas Seoh, J.D.